Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Metabolic trap
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Video|id=uej1LXzRbnY|service=youtube|dimensions=550|description=The Metabolic Trap theory in ME/CFS by [[Robert Phair]], Nov 2018, [[Open Medicine Foundation]] conference. [https://www.omf.ngo/wp-content/uploads/2018/11/Edited-Robert-Phair-Metabolic-Trap.pdf Transcript]|alignment=right|urlargs=start=0&rel=0&autoplay=0}} Metabolic Trap is a medical hypothesis that attempts to explain [[ME/CFS]] as a vicious cycle that is potentiated by common genetic mutations, triggered by a stressor, and is difficult to escape without intervention.<ref name="transcript112018">{{Cite web|url=https://www.omf.ngo/wp-content/uploads/2018/11/Edited-Robert-Phair-Metabolic-Trap.pdf | title=Metabolic Trap presentation (transcript) | last = Phair | first = Robert | authorlink=Robert Phair | date = Nov 2018 | website = [[Open Medicine Foundation]]|archive-url=|archive-date=|url-status=|access-date=}}</ref>{{Rp|6}}<ref name="Phair2019" /> == Background == When the [[Open Medicine Foundation|Open Medicine Foundation's]] Severely Ill Big Data study found some unexpected anomalies in ME/CFS patients, Dr [[Robert Phair]] investigated these further, and consulted with Ron Davis and others, and developed the "metabolic trap hypothesis".<ref name="transcript112018" /> ==Theory== The hypothesis is based on the idea that one or more important metabolic pathways may exhibit bistability. Thus, the pathway has two stable equilibrium states. One state is healthy, whereas the other is pathological. The bistability is believed to arise from one or more genetic mutations that cause the activity of an enzyme to decrease when the concentration of its substrate increases beyond a certain threshold. Under ordinary circumstances, the concentration of the substrate would remain below the threshold, keeping a person in the healthy state. But once environmental conditions cause the substrate to increase beyond the threshold, a person would enter the pathological state and remain in it even if the environment returned to normal. The relevant genetic mutations are believed to be common in the general population. Thus, presence of one or more mutations is a risk factor, but alone is not sufficient to cause ME/CFS. ==Evidence== While Phair has stated that several candidate traps have been identified, presentations so far have focused on one particular candidate: the [[Kynurenine]] pathway. {{Video|id=uej1LXzRbnY|service=youtube|dimensions=550|description=The Metabolic Trap theory in ME/CFS by [[Robert Phair]], Nov 2018, [[Open Medicine Foundation]] conference. [https://www.omf.ngo/wp-content/uploads/2018/11/Edited-Robert-Phair-Metabolic-Trap.pdf Transcript]|alignment=right|urlargs=start=0&rel=0&autoplay=0}} Metabolic Trap is a medical hypothesis that attempts to explain [[ME/CFS]] as a vicious cycle that is potentiated by common genetic mutations, triggered by a stressor, and is difficult to escape without intervention.<ref name="transcript112018">{{Cite web|url=https://www.omf.ngo/wp-content/uploads/2018/11/Edited-Robert-Phair-Metabolic-Trap.pdf | title=Metabolic Trap presentation (transcript) | last = Phair | first = Robert | authorlink=Robert Phair | date = Nov 2018 | website = [[Open Medicine Foundation]]|archive-url=|archive-date=|url-status=|access-date=}}</ref>{{Rp|6}}<ref name="Phair2019" /> ==Background== When the [[Open Medicine Foundation|Open Medicine Foundation's]] Severely Ill Big Data study found some unexpected anomalies in ME/CFS patients, Dr [[Robert Phair]] investigated these further, and consulted with Ron Davis and others, and developed the "metabolic trap hypothesis".<ref name="transcript112018" /> ==Theory== The hypothesis is based on the idea that one or more important metabolic pathways may exhibit bistability. Thus, the pathway has two stable equilibrium states. One state is healthy, whereas the other is pathological. The bistability is believed to arise from one or more genetic mutations that cause the activity of an enzyme to decrease when the concentration of its substrate increases beyond a certain threshold. Under ordinary circumstances, the concentration of the substrate would remain below the threshold, keeping a person in the healthy state. But once environmental conditions cause the substrate to increase beyond the threshold, a person would enter the pathological state and remain in it even if the environment returned to normal. The relevant genetic mutations are believed to be common in the general population. Thus, presence of one or more mutations is a risk factor, but alone is not sufficient to cause ME/CFS. ==Evidence == While Phair has stated that several candidate traps have been identified, presentations so far have focused on one particular candidate: the [[Kynurenine]] pathway. === Kynurenine pathway=== [[File:IDO-MetabolicTrap-MECFS.png|thumb|right|'''An IDO metabolic trap in the kynurenine pathway may be the cause of ME/CFS.''' Colored rectangles represent molecules in either extracellular space or serotonergic neuron cytosol. Arrows represent processes including transport and biochemical reactions. LAT1 = large neutral amino acid transporter (SLC7A5:SLC3A2), IDO = indoleamine-2,3-dioxygenase, AFMID = arylforamidase, TPH = tryptophan hydroxylase, AADC = aromatic amino acid decarboxylase. ''Citation: [https://www.mdpi.com/2075-4418/9/3/82 Phair, Davis and Kashi (2019). Diagnostics (9)3. doi 10.3390/diagnostics9030082]'']] There is, as yet, little evidence for a strong role of the kyneruinine pathway in ME/CFS. Current research suggests involvement in the condition, but no more-so than would be expected based on the fact that the kyneurnine pathway has a wide variety of roles in inflammation, the immune response, and metabolism. As a result the metabolic trap hypothesis, while a valuable theory, should not be expected to have a great deal of explanatory power in the etiology of CFS *CFS/ME patients do appear to exhibit mild over-representation of loss of function mutations in IDO2 gene <ref name="WarrenTate2023">{{Cite web |last=Tate |first=Warren |date=25 May 2022 |title=Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses |website=Frontiers in Neurology |url=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.877772/full?mibextid=ghrler&fs=e&s=cl |access-date=11 February 2023}}</ref> *The levels of KP metabolites in patients, while pointing to KP dysregulation, are not consistently correlated in the ways expected assuming a strong role for the metabolic trap in ME/CFS. Some studies do report higher TRP/KYN ratios in patients with CFS <ref name="Johnson2018">{{Cite web |last=Johnson |first=Cort |date=19 October 2018 |title=HealthRising: The Metabolic Trap Shines During the Symposium on the Molecular Basis of ME/CFS at Stanford |website=Open Medicine Foundation |url=https://www.omf.ngo/2018/10/19/healthrising-the-metabolic-trap-shines-during-the-symposium-on-the-molecular-basis-of-me-cfs-at-stanford/ |access-date=3 June 2019}}</ref>, while others report a lower KA/QA ratios, and a recent study showing higher levels of 3HK. Perhaps most relevantly, the finding in one study that there's no relationship between KP levels, cytokines and fatty acids <ref name="Kavyani2022">{{Cite web |last=Kavyani |first=Bahar |date=11 July 2022 |title=Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle? |website=PubMed Central (PMC) |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276562/ |access-date=11 February 2023}}</ref> *Computer simulation results showing the trap would be very difficult to escape, but would be sudden when it does occur. This is consistent with the real world observation that recovery from ME/CFS is rare, but sometimes happens very suddenly. ==Common and rare genetic mutations== The results from the [[ME/CFS Severely Ill, Big Data Study]] identified the variants [[R248W]], [[Y359STOP]], [[I140V]], [[S252T]] and [[N257K]] in the [[IDO2]] gene as being potentially damaging.<ref name="Phair2019" /> At least two of these five mutations were found in 85% of the severely ill ME patients.<ref name="Phair2019" /> ==Treatment== Dr. [[Ron Davis]] has stated that if the IDO metabolic trap hypothesis is true, then he believes that ME/CFS would be curable.{{citation needed}} Moreover, the cure would not require development of a new drug (which is both costly and time-consuming).{{citation needed}} However, development of a treatment has not yet begun as the hypothesis has not yet been confirmed. Importantly, Davis has expressed concern that patients may try to self-experiment with the kynurenine pathway because of the availability of substances like tryptophan on the open market. He cautioned that this is a dangerous pathway to experiment with, with particular risk of causing permanent autoimmunity which is not curable with present technology.<ref name="RonDavisNov2018">{{Cite web|url=https://www.youtube.com/watch?v=pFzOrknOylA&feature=youtu.be&list=PLl4AfLZNZEQPxjqF4ojAO3wdCFMeriNBK&t=663 | title = Ronald W. Davis, PhD {{!}} What's next? | last = Davis | first = Ronald | authorlink= | date = Nov 7, 2018 | website = YouTube|publisher=Open Medicine Foundation - OMF|archive-url=|archive-date=|url-status=|access-date=}}</ref> ==Notable studies and publications== *2019, The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS<ref name="Phair2019">{{Cite journal | last = Phair | first = Robert D. | authorlink = Robert Phair | last2 = Davis | first2 = Ronald W. | authorlink2 = Ron Davis | last3 = Kashi | first3 = Alex A. | authorlink3 = Alex Kashi | authorlink4 = | authorlink5 = | authorlink6 = | date = 2019 | title=The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS|url=https://www.mdpi.com/2075-4418/9/3/82|journal=Diagnostics|language=en|volume=9|issue=3 | pages = 82|doi=10.3390/diagnostics9030082|quote=|via=}}</ref> [https://www.mdpi.com/2075-4418/9/3/82/htm (Full text)] ==See also== *[[Indoleamine-2,3-dioxygenase 1]] (IDO1) *[[Open Medicine Foundation]] *[[Ron Davis]] *[[Robert Phair]] *[[ME/CFS Severely Ill, Big Data Study]] *[[How to check DNA data for certain genes]] ==Learn more== *[https://solvecfs.org/the-ido-metabolic-trap-hypothesis-for-me-cfs/ The IDO metabolic trap hypothesis for ME/CFS] - Christopher Armstrong *[https://www.youtube.com/watch?v=uej1LXzRbnY Robert Phair, PhD | Metabolic Traps: A new way to think about ME/CFS] (video) - [https://www.omf.ngo/wp-content/uploads/2018/11/Edited-Robert-Phair-Metabolic-Trap.pdf View Transcript] *[https://www.youtube.com/watch?v=F9T8qaaU78g Dr Phair Stanford Symposium 2018 metabolic trap] *[https://www.omf.ngo/2018/10/19/healthrising-the-metabolic-trap-shines-during-the-symposium-on-the-molecular-basis-of-me-cfs-at-stanford/ HealthRising: The Metabolic Trap Shines During the Symposium on the Molecular Basis of ME/CFS at Stanford] ==References== {{reflist}} [[Category:Medical hypotheses]] ==Common and rare genetic mutations== The results from the [[ME/CFS Severely Ill, Big Data Study]] identified the variants [[R248W]], [[Y359STOP]], [[I140V]], [[S252T]] and [[N257K]] in the [[IDO2]] gene as being potentially damaging.<ref name="Phair2019" /> At least two of these five mutations were found in 85% of the severely ill ME patients.<ref name="Phair2019" /> ==Treatment== Dr. [[Ron Davis]] has stated that if the IDO metabolic trap hypothesis is true, then he believes that ME/CFS would be curable.{{citation needed}} Moreover, the cure would not require development of a new drug (which is both costly and time-consuming).{{citation needed}} However, development of a treatment has not yet begun as the hypothesis has not yet been confirmed. Importantly, Davis has expressed concern that patients may try to self-experiment with the kynurenine pathway because of the availability of substances like tryptophan on the open market. He cautioned that this is a dangerous pathway to experiment with, with particular risk of causing permanent autoimmunity which is not curable with present technology.<ref name="RonDavisNov2018">{{Cite web|url=https://www.youtube.com/watch?v=pFzOrknOylA&feature=youtu.be&list=PLl4AfLZNZEQPxjqF4ojAO3wdCFMeriNBK&t=663 | title = Ronald W. Davis, PhD {{!}} What's next? | last = Davis | first = Ronald | authorlink= | date = Nov 7, 2018 | website = YouTube|publisher=Open Medicine Foundation - OMF|archive-url=|archive-date=|url-status=|access-date=}}</ref> ==Notable studies and publications== *2019, The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS<ref name="Phair2019">{{Cite journal | last = Phair | first = Robert D. | authorlink = Robert Phair | last2 = Davis | first2 = Ronald W. | authorlink2 = Ron Davis | last3 = Kashi | first3 = Alex A. | authorlink3 = Alex Kashi | authorlink4 = | authorlink5 = | authorlink6 = | date = 2019 | title=The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS|url=https://www.mdpi.com/2075-4418/9/3/82|journal=Diagnostics|language=en|volume=9|issue=3 | pages = 82|doi=10.3390/diagnostics9030082|quote=|via=}}</ref> [https://www.mdpi.com/2075-4418/9/3/82/htm (Full text)] ==See also== *[[Indoleamine-2,3-dioxygenase 1]] (IDO1) *[[Open Medicine Foundation]] *[[Ron Davis]] *[[Robert Phair]] *[[ME/CFS Severely Ill, Big Data Study]] *[[How to check DNA data for certain genes]] ==Learn more== *[https://solvecfs.org/the-ido-metabolic-trap-hypothesis-for-me-cfs/ The IDO metabolic trap hypothesis for ME/CFS] - Christopher Armstrong *[https://www.youtube.com/watch?v=uej1LXzRbnY Robert Phair, PhD | Metabolic Traps: A new way to think about ME/CFS] (video) - [https://www.omf.ngo/wp-content/uploads/2018/11/Edited-Robert-Phair-Metabolic-Trap.pdf View Transcript] *[https://www.youtube.com/watch?v=F9T8qaaU78g Dr Phair Stanford Symposium 2018 metabolic trap] *[https://www.omf.ngo/2018/10/19/healthrising-the-metabolic-trap-shines-during-the-symposium-on-the-molecular-basis-of-me-cfs-at-stanford/ HealthRising: The Metabolic Trap Shines During the Symposium on the Molecular Basis of ME/CFS at Stanford] ==References== {{reflist}} [[Category:Medical hypotheses]]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Category handler
(
edit
)
Template:Citation needed
(
edit
)
Template:Cite journal
(
edit
)
Template:Cite web
(
edit
)
Template:Colon
(
edit
)
Template:Fix
(
edit
)
Template:Fix/category
(
view source
) (protected)
Template:GetFallback
(
edit
)
Template:LangSwitch
(
edit
)
Template:Main other
(
edit
)
Template:Reflist
(
edit
)
Template:Rp
(
edit
)
Template:Uselang
(
edit
)
Template:Video
(
edit
)
Module:Arguments
(
edit
)
Module:Category handler
(
edit
)
Module:Category handler/blacklist
(
edit
)
Module:Category handler/config
(
edit
)
Module:Category handler/data
(
edit
)
Module:Category handler/shared
(
edit
)
Module:Check for unknown parameters
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:Namespace detect/config
(
edit
)
Module:Namespace detect/data
(
edit
)
Module:No globals
(
edit
)
Module:Unsubst
(
edit
)
Module:Yesno
(
edit
)
This page is a member of 2 hidden categories:
Category:All articles with unsourced statements
Category:Articles with unsourced statements from unknown year
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs